Polo-like kinase 3 inhibits glucose metabolism in colorectal cancer by targeting HSP90/STAT3/HK2 signaling

BACKGROUND: Polo-like kinase 3 (PLK3) has been documented as a tumor suppressor in several types of malignancies. However, the role of PLK3 in colorectal cancer (CRC) progression and glucose metabolism remains to be known. METHODS: The expression of PLK3 in CRC tissues was determined by immunohistoc...

Descripción completa

Detalles Bibliográficos
Autores principales: Ou, Baochi, Sun, Hongze, Zhao, Jingkun, Xu, Zhuoqing, Liu, Yuan, Feng, Hao, Peng, Zhihai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6815449/
https://www.ncbi.nlm.nih.gov/pubmed/31655629
http://dx.doi.org/10.1186/s13046-019-1418-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6815449/
https://www.ncbi.nlm.nih.gov/pubmed/31655629
http://dx.doi.org/10.1186/s13046-019-1418-2

Ejemplares similares